Flashes of insight trigger activity in the brain’s hippocampus. This cashew-shaped structure is buried deep within the ...

Have you ever been stuck on a problem, puzzling over something for what felt like ages without getting anywhere, but then suddenly the answer came to you like a bolt from the blue?

The Bi-GRU network is used to further extract the deep temporal features. A Gradient Reversal Layer (GRL) is introduced between the domain discriminator and the feature extractor to promote the ...

Abstract: With the advent of deep learning, various deep neural network architectures have been proposed to capture the complex spatio-temporal dependencies in traffic data. This paper introduces a ...

AbbVie’s Rinvoq (upadacitinib) has been approved by the US Food and Drug Administration (FDA) to treat adults with giant cell arteritis (GCA), or temporal arteritis, an autoimmune disease of medium ...

At the center of this complex neural circuitry is the hippocampus, located deep in the temporal lobe of the brain and responsible for forming new memories, learning, and emotions. The Mount Sinai ...

The Metals Company and the Trump administration are trying to circumvent international deep sea mining rules. The Metals Company and the Trump administration are trying to circumvent international ...

Journal of Nuclear Medicine April 2025, jnumed.124.268706; DOI: https://doi.org/10.2967/jnumed.124.268706 ...

NORTH CHICAGO, Ill., April 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ ® (upadacitinib), 15 mg, once daily, for ...

The US Food and Drug Administration (FDA) has approved a new indication for upadacitinib as a treatment for giant cell arteritis (GCA) in adults. This is the first oral JAK inhibitor indicated for ...

The FDA has approved upadacitinib to treat adults with giant cell arteritis. It is the second drug to be specifically approved for the disease in the United States after tocilizumab in 2017.